tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RXRX Stock Latest News

Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
Company AnnouncementsRecursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
17d ago
8K
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
17d ago
RXRX
Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader
PremiumMarket News
Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader
17d ago
NVDA
Recursion announces first patient dosed in Phase 1/2 trial of REC-1245
PremiumThe Fly
Recursion announces first patient dosed in Phase 1/2 trial of REC-1245
17d ago
RXRX
Unusually active option classes on open December 2nd
PremiumThe Fly
Unusually active option classes on open December 2nd
18d ago
ZS
CNM
Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals today
PremiumThe FlyCathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals today
30d ago
RXRX
Unusually active option classes on open November 20th
Premium
The Fly
Unusually active option classes on open November 20th
1M ago
U
CVS
Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
Premium
Company Announcements
Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
1M ago
8K
RXRX
Recursion, Exscientia officially combine to advance drug discovery
PremiumThe Fly
Recursion, Exscientia officially combine to advance drug discovery
1M ago
EXAI
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
1M ago
RXRX
Recursion, Exscientia shareholders approve proposed combination
PremiumThe Fly
Recursion, Exscientia shareholders approve proposed combination
1M ago
EXAI
RXRX
Recursion Pharmaceuticals Reports Q3 2024 Earnings and Strategic Milestones
PremiumCompany Announcements
Recursion Pharmaceuticals Reports Q3 2024 Earnings and Strategic Milestones
1M ago
RXRX
Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
PremiumThe FlyClosing Bell Movers: AppLoving up 29% after Q3 earnings beat
1M ago
Z
DV
Recursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)
Premium
The Fly
Recursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)
1M ago
RXRX
Recursion Pharmaceuticals Advances Drug Discovery and Partnerships
Premium
Company Announcements
Recursion Pharmaceuticals Advances Drug Discovery and Partnerships
1M ago
8K
RXRX
Cathie Wood’s ARK Investment buys 106K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 106K shares of Recursion Pharmaceuticals today
2M ago
RXRX
Cathie Wood’s ARK Investment buys 729K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 729K shares of Recursion Pharmaceuticals today
2M ago
RXRX
Cathie Wood’s ARK Investment buys 331K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 331K shares of Recursion Pharmaceuticals today
2M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion Pharmaceuticals doses first patient in Phase 2 trial of REC-3964
PremiumThe FlyRecursion Pharmaceuticals doses first patient in Phase 2 trial of REC-3964
2M ago
RXRX
Cathie Wood’s ARK Investment buys 425K shares of Recursion Pharmaceuticals today
Premium
The Fly
Cathie Wood’s ARK Investment buys 425K shares of Recursion Pharmaceuticals today
2M ago
RXRX
Cathie Wood’s ARK Investment buys 124K shares of Recursion Pharmaceuticals today
Premium
The Fly
Cathie Wood’s ARK Investment buys 124K shares of Recursion Pharmaceuticals today
2M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >